<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">670813</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.670813</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>M2 Macrophages Promote PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes Migration After Spinal Cord Injury in Mice <italic>via</italic> PDGFB/PDGFR&#x3b2; Pathway</article-title>
<alt-title alt-title-type="left-running-head">Li et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">PDGFB Promotes PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes Migration</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Ziyu</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1241802/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Meige</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Shuisheng</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yao</surname>
<given-names>Fei</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Yang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yanchang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Dasheng</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cheng</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jing</surname>
<given-names>Juehua</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff>Department of Orthopaedics, The Second Hospital of Anhui Medical University, <addr-line>Hefei</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/830519/overview">Sung Hwan Ki</ext-link>, Chosun University, South Korea</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/818630/overview">Young-Chang Cho</ext-link>, Chonnam National University, South Korea</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/257707/overview">Gum Hwa Lee</ext-link>, Chosun University, South Korea</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Juehua Jing, <email>jjhhu@sina.com</email>; Li Cheng, <email>chengli7788@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>670813</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>02</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>03</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Li, Zheng, Yu, Yao, Luo, Liu, Tian, Cheng and Jing.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Li, Zheng, Yu, Yao, Luo, Liu, Tian, Cheng and Jing</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Platelet derived growth factor receptor &#x3b2; positive (PDGFR&#x3b2;<sup>&#x2b;</sup>) pericytes form fibrotic scar, which prevents axonal regeneration after spinal cord injury (SCI). However, the mechanism by which PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migrate to the injury core is unclear. Here, we investigated the effect and mechanism of macrophages polarization on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after SCI. Macrophages were closely related to the spatiotemporal distribution of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes in the injury core at 3, 7, and 14&#xa0;days postinjury (dpi). Macrophages appeared M2 polarization at 3 and 7&#xa0;dpi while M1 polarization at 14&#xa0;dpi. The expression of platelet derived growth factor B (PDGFB) was significantly increased after SCI and after macrophages M2 polarization. The promoting effect of exogenous PDGFB and M2 macrophages conditioned medium on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration could be blocked by SU16f, a PDGFR&#x3b2; specific inhibitor. These findings indicate that M2 macrophages can secrete PDGFB acting on PDGFR&#x3b2; to promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration, which can be blocked by a PDGFR&#x3b2; specific inhibitor SU16f. The PDGFB/PDGFR&#x3b2; pathway is a promising new target for the treatment of&#x20;SCI.</p>
</abstract>
<kwd-group>
<kwd>spinal cord injury</kwd>
<kwd>M2 macrophages</kwd>
<kwd>PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes</kwd>
<kwd>PDGFR&#x3b2;</kwd>
<kwd>fibrotic scar</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Spinal cord injury (SCI) is a devastating injury resulting in severe and sustained sensory and motor dysfunction in patients, and there is no effective clinical treatment (<xref ref-type="bibr" rid="B22">Selvarajah et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B4">Bellver-Landete et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B19">Kobayakawa et&#x20;al., 2019</xref>). In the acute phase of SCI, physical trauma leads directly to the disruption of the blood&#x2013;spinal cord barrier and bleeding, followed by the infiltration of blood-derived macrophages (<xref ref-type="bibr" rid="B6">David and Kroner, 2011</xref>). Oxidative stress caused by ischemia-reperfusion injury and a large number of inflammatory factors released by macrophages further aggravate inflammation, which contributes to neuronal and glial apoptosis (<xref ref-type="bibr" rid="B12">Hausmann, 2003</xref>; <xref ref-type="bibr" rid="B21">Muradov et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B26">Tran et&#x20;al., 2018</xref>). In the subacute phase of SCI, platelet derived growth factor receptor &#x3b2; positive (PDGFR&#x3b2;<sup>&#x2b;</sup>) pericytes gradually migrate and aggregate to the injury core and deposit extracellular matrix, which surround macrophages and form fibrotic scar (<xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B24">Soderblom et&#x20;al., 2013</xref>). Although fibrotic scar prevents the spread of inflammation, it inhibits axonal regeneration in the chronic phase of SCI (<xref ref-type="bibr" rid="B17">Klapka et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B7">Dias et&#x20;al., 2018</xref>). The removal of fibrotic scar contributes to axonal regeneration suggesting that fibrotic scar may be a target for clinical treatment (<xref ref-type="bibr" rid="B17">Klapka et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B7">Dias et&#x20;al., 2018</xref>). However, the mechanisms of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration and extracellular matrix deposition are still unclear.</p>
<p>The clearance of blood-derived macrophages resulted in the reduction of fibrotic scar in the injury core after SCI in mice, suggesting that macrophages may be involved in PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration (<xref ref-type="bibr" rid="B29">Zhu et&#x20;al., 2015a</xref>). Moreover, macrophages have different functions due to M1 or M2 polarization in many diseases, which is important for oxidative stress, immune response and homeostasis repair (<xref ref-type="bibr" rid="B16">Kigerl et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B6">David and Kroner, 2011</xref>; <xref ref-type="bibr" rid="B28">Wang et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B27">Wang et&#x20;al., 2019</xref>). It has been shown that platelet derived growth factor (PDGFB) can activate PDGFR&#x3b2; to regulate pericyte migration in angiopoiesis, fibrosarcoma and retinal tissue (<xref ref-type="bibr" rid="B2">Abramsson et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B1">Abramsson et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B25">Stratman et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B8">Dubrac et&#x20;al., 2018</xref>). However, the effects of macrophages polarization and PDGFB/PDGFR&#x3b2; pathway on the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to the injury core after SCI have not been reported.</p>
<p>In this study, we found that macrophages are closely related to the spatiotemporal distribution of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes in the injury core at 3, 7, and 14days postinjury (dpi). Macrophages appear M2 polarization at 3 and 7dpi while M1 polarization at 14 dpi. M2 macrophages can secrete PDGFB acting on PDGFR&#x3b2; to promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration, which can be blocked by SU16f, a PDGFR&#x3b2; specific inhibitor. Besides, M2 macrophages can promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to secrete extracellular matrix. These suggested that PDGFB/PDGFR&#x3b2; pathway is a promising new target for the treatment of&#x20;SCI.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals and Cells</title>
<p>All animal experiments were approved by the Animal Ethics Committee of Anhui Medical University (Approval No. LLSC20160052). 20&#x2013;25&#xa0;g mice were purchased from the Animal Experiment Center of Anhui Medical University. All mice were bred in the Research and Experimental Center of the Second Hospital of Anhui Medical University. The temperature and humidity were controlled in the feeding environment, with a 12&#xa0;h cycle of light and darkness, and food and water were readily available. Mouse mononuclear macrophage leukemia cells RAW 264.7 were cultured in DMEM (Hyclone, Invitrogen, United&#x20;States) containing 10% FBS (Gibco, United&#x20;States), 1% Glutamax and 1% Sodium Pyruvate (Invitrogen, United&#x20;States), and were kindly provided by Stem Cell Bank, Chinese Academy of Sciences (Shanghai, China). Mouse brain vascular pericytes MBVP were kindly provided by Mingzhou Biological Technology (Ningbo, China), and were cultured in DMEM containing 10% FBS. The cells were cultured at 5% CO<sub>2</sub> and 37&#xb0;C. MBVP cells were identified as PDGFR&#x3b2;<sup>&#x2b;</sup> cells <italic>via</italic> immunocytochemistry and could be used as a model of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes <italic>in&#x20;vitro</italic>.</p>
</sec>
<sec id="s2-2">
<title>Establishment of Mouse Spinal Cord Compression Injury Model</title>
<p>Each mouse was given water fasting before surgery. The mice were put in prone position after satisfactory anesthesia with isoflurane (induction 4%, maintenance 2%). After shaving the dorsal surface of the mouse and disinfecting the skin, T10 segment of spinal cord was exposed. The T10 spinal cord was clamped with the calibrated Dumont &#x23;5 forceps (11252-20, Fine Science Tools, Germany) for 5&#xa0;s (<xref ref-type="bibr" rid="B20">McDonough et&#x20;al., 2015</xref>). The incisions were sterilized and stitched layer by layer. The mice were routinely treated with anti-infection and auxiliary urination nursing after&#x20;SCI.</p>
</sec>
<sec id="s2-3">
<title>Establishment of Macrophages Polarization Model and Extraction of Conditioned Medium</title>
<p>RAW 264.7 cells were plated in 6-well plates at a density of 2&#x20;&#xd7; 10<sup>5</sup>/ml and cultured overnight. After serum deprivation for 24&#xa0;h, RAW 264.7&#xa0;cells were treated with LPS (100&#xa0;ng/ml, Beyotime Biotechnology, China) plus IFN&#x3b3; (20&#xa0;ng/ml, Beyotime Biotechnology, China) for M1 polarization or IL-4 (20&#xa0;ng/ml, Beyotime Biotechnology, China) for M2 polarization, and the cells were cultured for 24&#xa0;h. Then, the cell culture medium was replaced with serum-free DMEM for another 24&#xa0;h. Supernatant was collected and centrifuged (1200&#xa0;rpm, 5&#xa0;min) as conditioned medium including conditioned medium of M0 (CM0), CM1, and CM2. WB and immunocytochemistry were used to identify the macrophage polarization model, and ELISA was used to identify the conditioned medium.</p>
</sec>
<sec id="s2-4">
<title>Immunofluorescence Staining</title>
<p>The mice underwent thoracotomy after satisfactory anesthesia. After cardiac perfusion with PBS and 4% paraformaldehyde (4% PFA, Servicebio, China), spinal cord containing the injured core (5&#xa0;mm) was removed and fixed in 4% PFA overnight. Then, the tissue blocks were dehydrated, made transparent, dipped in wax, embedded, and sliced to 6&#xa0;&#xb5;m thickness serial sections using a microtome (RM2235, Leica, Germany). The sections were deparaffinized and rehydrated in turn. Antigen retrieval was performed using the microwave method, followed by washing with PBS and blocking in 5% donkey serum (SL050, Solarbio, China) in PBS with 0.3% Triton-X100 for 1&#xa0;h at room temperature. The primary antibodies were incubated at 4&#xb0;C overnight: Goat anti-PDGFR&#x3b2; (5&#xa0;&#xb5;g/ml, AF1042-SP, R&#x26;D Systems, United&#x20;States), Mouse anti-Mac2 (1:100, GB12246, Servicebio, China), Rabbit anti-iNOS (1:100, AF0199, Affinity, United&#x20;States) and Rabbit anti-CD206 (1:100, ab64693, Abcam, China). The secondary antibodies were incubated at 37&#xb0;C in dark for 1&#xa0;h: Donkey anti-Rabbit Alexa Fluor 488, Donkey anti-Mouse Alexa Fluor 594, Donkey anti-Goat Alexa Fluor 488 and Donkey anti-Goat Alexa Fluor 594 (1:500, A-21206, A-21203, A-11055, A-11058, Invitrogen, United&#x20;States). Finally, the anti-fluorescence quencher (P0126, Beyotime Biotechnology, China) was used to seal the sections. The representative images were obtained using fluorescence microscope (Axio Scope A1, Zeiss, Germany) by comparing and processing all images of the same light intensity and filtering.</p>
</sec>
<sec id="s2-5">
<title>Immunocytochemistry Staining</title>
<p>Cells were fixed with 4% PFA for 10&#x2013;15&#xa0;min and blocked for 30&#xa0;min at room temperature. Primary antibodies were diluted in blocking solution and applied for overnight at 4&#xb0;C: Goat anti-PDGFR&#x3b2; (5&#xa0;&#xb5;g/ml, AF1042-SP, R&#x26;D Systems, United&#x20;States), Rabbit anti-iNOS (1:100, AF0199, Affinity, United&#x20;States), Rabbit anti-CD206 (1:100, ab64693, Abcam, China) and Rabbit anti-Laminin (1:100, 23498-1-AP, Proteintech, China). Secondary antibody incubation as shown above, and blue counterstaining (DAPI, C0065, Solarbio, China) showed nuclei. Finally, the anti-fluorescence quencher was used to seal the sections. The representative images were obtained as above. Image J (NIH, United&#x20;States) was used for quantitative analysis.</p>
</sec>
<sec id="s2-6">
<title>Western Blot Assay</title>
<p>For cell proteins, cells were washed with PBS and lysed using RIPA buffer (P0013B, Beyotime Biotechnology, China) supplemented with Protease Inhibitor Cocktail and Phosphatase Inhibitor (04693124001, 04906845001, Roche, Switzerland). For spinal cord tissue proteins, after cardiac perfusion with PBS, the spinal cord (3&#xa0;mm) containing the injury core was removed and lysed with lysis buffer mentioned above. The supernatant was collected as total protein. Protein concentrations were determined using bicinchoninic acid (BCA) kit (P0012S, Beyotime Biotechnology, China) and diluted to 1&#xa0;mg/ml for each sample. 20&#xa0;&#x3bc;g of protein was denatured at 100&#xb0;C for 10&#xa0;min in LDS Sample Buffer (NP0007, Invitrogen, Unites States) before being resolved on SDS-PAGE electrophoresis and transferred onto a Polyvinylidene difluoride (PVDF) membranes. Blots were blocked in 5% nonfat milk and probed with primary antibodies against at 4&#xb0;C overnight: Rabbit anti-iNOS (1:2000, AF0199, Affinity, United&#x20;States), Rabbit anti-CD206 (1:1,000, ab64693, Abcam, China), Goat anti-PDGFR&#x3b2; (0.25&#xa0;&#xb5;g/ml, AF1042-SP, R&#x26;D Systems, United&#x20;States), Mouse anti-PDGFB (1:500, SC-365805, Santa Cruz, United&#x20;States), Mouse anti-PDGFD (1:500, 14075-1-AP, Proteintech, China), Rabbit anti-Laminin (1:1000, 23498-1-AP, Proteintech, China), Mouse anti-&#x3b2;-Tubulin (1:10000, T0023, Affinity, Unites States) and Mouse anti-GAPDH (1:1000, ab8245, Abcam, China). The membranes were incubated with secondary antibodies for 1&#xa0;h at room temperature: Goat anti-Mouse (1:10000, A4416, Sigma, United&#x20;States), Goat anti-Rabbit (1:10000, A0545, Sigma, United&#x20;States) or Rabbit anti-Goat (1:10000, A8919, Sigma, United&#x20;States). The protein band signals were obtained using Tanon 5200 system (Tanon, China). Image J (NIH, United&#x20;States) was used for quantitative analysis.</p>
</sec>
<sec id="s2-7">
<title>Enzyme-Linked Immunosorbent Assay (ELISA)</title>
<p>The PDGFB ELISA kit (KE10034, Proteintech, China) was used to detect the concentration of PDGFB in the conditioned medium of different polarized macrophages. The supernatant was collected and centrifuged (1200&#xa0;rpm, 5&#xa0;min) for detection immediately, according to the kit&#x2019;s instruction.</p>
</sec>
<sec id="s2-8">
<title>Scratch Test</title>
<p>The marker pen was used to draw 3 horizontal lines evenly on the back of the 6-well plate at intervals of 1&#xa0;cm. MBVP cells were plated in 6-well plates at a density of 2&#x20;&#xd7; 10<sup>5</sup>/ml and cultured until the cells covered the entire plate bottom. The wound was created using a sterile 200&#xa0;&#x3bc;l pipette tip. After washing off the exfoliated cells, macrophages conditioned medium, serum-free DMEM containing recombinant mouse PDGFB protein (10&#xa0;ng/ml, NBP2-53416, Novus, United&#x20;States) or serum-free DMEM containing SU16f (10&#xa0;&#x3bc;m, 3304, R&#x26;D Systems, United&#x20;States) were added to the 6-well plate to regulate MBVP cells migration for 72&#xa0;h. The pictures of scratch wounds were taken at 0 and 72&#xa0;h and assessed using the Image J software.</p>
</sec>
<sec id="s2-9">
<title>Transwell Test</title>
<p>The 24-well plate containing 8&#xa0;&#x3bc;m chamber (Corning, United&#x20;States was used to detect the migration ability of cells. MBVP cells were inoculated to the upper chamber at a density of 1&#x20;&#xd7; 10<sup>6</sup>/100&#xa0;&#x3bc;l. According to the experimental requirements, macrophages conditioned medium or PDGFB (10&#xa0;ng/ml, NBP2-53416, Novus, United&#x20;States) were added to the lower chamber to regulate MBVP cells migration, or SU16f (10&#xa0;&#x3bc;m, 3304, R&#x26;D Systems, United&#x20;States) was added to the upper chamber to block PDGFR&#x3b2;. After 24&#xa0;h in an incubator at 37&#xb0;C and 5% CO<sub>2</sub>, a cotton swab was used to wipe off the cells in the inner layer of chamber. After washing with ddH<sub>2</sub>O water twice, the chambers were fixed by 4% PFA at room temperature for 20&#xa0;min. After washing with ddH<sub>2</sub>O water twice, crystal violet (C0121, Beyotime Biotechnology, China) staining was performed for 15&#xa0;min. The cells were observed under the microscope and counted.</p>
</sec>
<sec id="s2-10">
<title>Statistical Analysis</title>
<p>The data were presented as means&#x20;&#xb1; standard deviation. Multiple-group comparisons were statistically analyzed with one-way analysis of variance (ANOVA) followed by the Tukey method or nonparametric test using the Prism 8.3.0 software (GraphPad, United&#x20;States). <italic>p &#x3c;</italic> 0.05 was considered significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>The Spatiotemporal Distribution of Macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes is Closely Related After Spinal Cord Injury</title>
<p>To further confirm the spatiotemporal distribution of macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after SCI, the goat anti-PDGFR&#x3b2; antibody was used to specifically label PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes while the mouse anti-Mac2 antibody was used to specifically label blood-derived macrophages rather than microglia (<xref ref-type="bibr" rid="B28">Wang et&#x20;al., 2015</xref>). The immunofluorescence staining showed that there was no obvious aggregation of macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes in the normal spinal cord. Macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes were scattered at the injury core at 3&#xa0;dpi while significantly aggregated at the injury core at 7&#xa0;dpi. Finally, PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes surrounded macrophages to form fibrotic scar at 14&#xa0;dpi (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). During 3&#x2013;14&#xa0;dpi, PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes gradually migrated and aggregated to the injury core, and the spatiotemporal distribution between macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes was closely related (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). These suggested that 3&#x2013;7&#xa0;dpi is a critical period for PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to migrate and aggregate to the injury core, and macrophages may be involved in the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after&#x20;SCI.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Spatiotemporal distribution of macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after SCI in mice. Immunofluorescence staining was used to detect the distribution of macrophages (Mac2<sup>&#x2b;</sup>, red) and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes (PDGFR&#x3b2;<sup>&#x2b;</sup>, green) before (Pre) and at 3, 7, and 14&#xa0;dpi in the injury core (<italic>n</italic>&#x20;&#x3d; 3 per group). Representative fluorescence images were presented. Scale bars, 500&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fphar-12-670813-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Macrophages Appear M1 or M2 Polarization After Spinal Cord Injury</title>
<p>To investigate the effect of macrophages polarization on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration, anti-iNOS antibody and anti-CD206 antibody were used to specifically label M1 and M2 macrophages respectively to observe the macrophages polarization after SCI. The immunofluorescence staining showed that the macrophages (Mac2<sup>&#x2b;</sup>) were mainly of type M2 with CD206<sup>&#x2b;</sup> and iNOS<sup>&#x2212;</sup> in injury core at 3 and 7&#xa0;dpi (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>) while the macrophages were mainly of type M1 with iNOS<sup>&#x2b;</sup> and CD206<sup>&#x2212;</sup> in injury core at 14&#xa0;dpi (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). It was interesting to note that macrophages were mainly type M2 in the critical period of 3&#x2013;7&#xa0;dpi during when PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migrated and aggregated to the injury core (<xref ref-type="fig" rid="F1">Figures 1</xref>, <xref ref-type="fig" rid="F2">2B</xref>). These suggested that M2 macrophages may be involved in the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after&#x20;SCI.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Macrophages polarization after SCI in mice. Immunofluorescence staining was used to detect Mac2<sup>&#x2b;</sup> (red) and iNOS<sup>&#x2b;</sup> (green) M1 macrophages in <bold>(A)</bold> or Mac2<sup>&#x2b;</sup> (red) and CD206<sup>&#x2b;</sup> (green) M2 macrophages in <bold>(B)</bold> at 3, 7, and 14&#xa0;dpi in the injury core (<italic>n</italic>&#x20;&#x3d; 3 per group). Representative fluorescence images were presented. Scale bars, 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fphar-12-670813-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Identification of PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes and Macrophages Polarization <italic>in Vitro</italic>
</title>
<p>To further investigate the effect of M2 macrophages on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration, RAW 264.7&#xa0;cells were used as the blood-derived macrophages model and MBVP cells as the PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes model <italic>in&#x20;vitro</italic>. The results of immunocytochemistry suggested that MBVP cells were PDGFR&#x3b2;<sup>&#x2b;</sup> cells and could be used as the PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes model <italic>in&#x20;vitro</italic> (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>)<italic>.</italic> In addition, we induced and identified M1 or M2 polarization of macrophages according to previous reports (<xref ref-type="bibr" rid="B16">Kigerl et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B13">Hiroi et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Fan et&#x20;al., 2020</xref>). The results of Western blot showed that compared with other groups, M1 macrophages significantly expressed iNOS while M2 macrophages significantly expressed CD206 (<italic>p</italic>&#x20;&#x3c; 0.0001 for iNOS, <italic>p</italic>&#x20;&#x3c; 0.001 for CD206, <xref ref-type="fig" rid="F3">Figures 3B&#x2013;D</xref>). Besides, immunocytochemistry was used to further confirm the reliability of macrophages polarization model. The results showed that compared with the other two groups, the fluorescence intensity of iNOS of M1 macrophages was significantly increased while that of CD206 of M2 macrophages was significantly increased (<xref ref-type="fig" rid="F3">Figure&#x20;3E</xref>). These suggested that the PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes model and macrophages polarization model could be used for the follow-up&#x20;study.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Identification of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes and polarized macrophages <italic>in&#x20;vitro</italic>. <bold>(A)</bold> Immunocytochemistry staining was used to detect PDGFR&#x3b2;<sup>&#x2b;</sup> (green) and DAPI-stained nuclei (blue) in MBVP cells. <bold>(B)</bold> Western blot was used to detect the expression levels of M1 (iNOS) or M2 (CD206) polarization markers in RAW 264.7 cells after polarization treatment. <bold>(C, D)</bold> Quantitative analysis of iNOS and CD206 expression. The blots (<italic>n</italic>&#x20;&#x3d; 5 per group) were quantified by a densitometric method using the ImageJ software. The results were expressed as mean&#x20;&#xb1; SD. &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001 (CM1 vs. other groups) in <bold>(C)</bold>; &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 (CM2 vs. other groups) in <bold>(D)</bold>. <bold>(E)</bold> Representative fluorescence images of iNOS and CD206 in RAW 264.7 cells after polarization treatment, DAPI stained the nuclei. Scale bars, 50&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fphar-12-670813-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>M2 Macrophages Promote the Migration of PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes <italic>in Vitro</italic>
</title>
<p>To further investigate the effect of macrophages polarization on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration, the conditioned medium of different polarized macrophages (CM0, CM1, and CM2) were extracted for culture of pericytes. The scratch test showed that after adding M2 conditioned medium, the wound closure rate of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes was significantly higher than that of other groups (<italic>p</italic>&#x20;&#x3c; 0.001 or <italic>p</italic>&#x20;&#x3c; 0.0001, <xref ref-type="fig" rid="F4">Figures 4A,C</xref>). Besides, transwell test was used to further show that the number of pericytes passing through membrane increased significantly after adding M2 conditioned medium compared with other groups (<italic>p</italic>&#x20;&#x3c; 0.001 or <italic>p</italic>&#x20;&#x3c; 0.0001, <xref ref-type="fig" rid="F4">Figures 4B,D</xref>). Compared with Sham group and CM1 group, the number of pericytes passing through membrane increased significantly after adding M0 conditioned medium (<italic>p</italic>&#x20;&#x3c; 0.001), but this effect was much weaker than M2 conditioned medium. These suggested that M2 macrophages could promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration <italic>in&#x20;vitro</italic>, possibly due to the secretion of certain cytokines.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>M2 macrophages promote the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes <italic>in&#x20;vitro</italic>. <bold>(A)</bold> Scratch test was used to detect the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after being treated with DMEM (Sham), conditioned medium of M0 macrophages (CM0), conditioned medium of M1 macrophages (CM1), or conditioned medium of M2 macrophages (CM2) for 72&#xa0;h (<italic>n</italic>&#x20;&#x3d; 3 per group). <bold>(B)</bold> Transwell test was used to further detect the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after being treated in Sham, CM0, CM1, or CM2 groups for 20&#xa0;h (<italic>n</italic>&#x20;&#x3d; 3 per group) <bold>(C)</bold> Quantitative analysis of the wound closure rate in <bold>(A)</bold>. The results were expressed as mean&#x20;&#xb1; SD. &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 (CM2 vs. Sham and CM0); <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.0001 (CM2 vs. CM1) <bold>(D)</bold> Quantitative analysis of the number of transmembrane cells in <bold>(B)</bold>. The results were expressed as mean&#x20;&#xb1; SD. &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001 (CM2 vs. Sham and CM1); <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 (CM2 vs. CM0). <sup>&#x26;&#x26;&#x26;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 (CM0 vs. Sham and CM1). Scale bars, 100&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fphar-12-670813-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>M2 Macrophages Promote PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes to Secrete Extracellular Matrix <italic>in Vitro</italic>
</title>
<p>PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes and extracellular matrix including Collagen, Fibronectin and Laminin together surround macrophages to form fibrotic scar after SCI (<xref ref-type="bibr" rid="B24">Soderblom et&#x20;al., 2013</xref>). It has been shown that Collagen and Fibronectin are mainly secreted by PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after SCI while the main cellular origin of Laminin is unclear (<xref ref-type="bibr" rid="B24">Soderblom et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B30">Zhu et&#x20;al., 2015b</xref>). The results of Western blot showed that after adding M2 conditioned medium, the expression level of Laminin in pericytes was significantly higher than that in other groups (<italic>p</italic>&#x20;&#x3c; 0.001, <xref ref-type="fig" rid="F5">Figures 5A,B</xref>). Besides, immunocytochemistry was used to further show that the fluorescence intensity of Laminin in pericytes cultured in M2 conditioned medium was significantly higher than that of other groups (<italic>p</italic>&#x20;&#x3c; 0.01, <xref ref-type="fig" rid="F5">Figures 5C,D</xref>). These suggested that Laminin may also be mainly secreted by PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes, and M2 macrophages can promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to secrete extracellular matrix <italic>in&#x20;vitro</italic>.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>M2 macrophages promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to secrete extracellular matrix Laminin <italic>in&#x20;vitro</italic>. <bold>(A)</bold> Western blot was used to detect the expression levels of Laminin in PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after being treated in Sham, CM0, CM1 or CM2 groups for 24&#xa0;h (<italic>n</italic>&#x20;&#x3d; 5 per group). <bold>(B)</bold> Quantitative analysis of Laminin expression. The blots were quantified as previously described. &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 (CM2 vs. other groups). <bold>(C)</bold> Immunocytochemistry staining was used to further confirm the expression levels of Laminin of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after being treated in Sham, CM0, CM1 or CM2 groups for 24&#xa0;h (<italic>n</italic>&#x20;&#x3d; 3 per group) <bold>(D)</bold> Quantitative analysis of fluorescence intensity in <bold>(C)</bold>. The results were expressed as mean&#x20;&#xb1; SD. &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 (CM2 vs. other groups). Scale bar, 25&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fphar-12-670813-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>The Expression of PDGFB is Significantly Increased After Spinal Cord Injury <italic>in Vivo</italic> and Macrophages M2 Polarization <italic>in Vitro</italic>
</title>
<p>PDGFR&#x3b2; is a specific marker for PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes while PDGFB can activate pericyte surface PDGFR&#x3b2; and regulate pericyte migration in the retinal tissue. Therefore, we further investigated whether PDGFB/PDGFR&#x3b2; pathway also plays an important role in the process of M2 macrophages promoting PDGFR&#x3b2;<sup>&#x2b;</sup> pericyte migration. Our results showed that the expression level of PDGFB increased significantly at 3 and 7&#xa0;dpi compared with Pre (<italic>p</italic>&#x20;&#x3c; 0.01 and <italic>p</italic>&#x20;&#x3c; 0.05, respectively), while decreased significantly at 14&#xa0;dpi compared with 3 and 7&#xa0;dpi (<italic>p</italic>&#x20;&#x3c; 0.001 and <italic>p</italic>&#x20;&#x3c; 0.01, respectively, <xref ref-type="fig" rid="F6">Figures 6A,B</xref>). The expression level of PDGFD was significantly decreased at 3, 7, and 14&#xa0;dpi compared with Pre (<italic>p</italic>&#x20;&#x3c; 0.0001, <xref ref-type="fig" rid="F6">Figures 6A,C</xref>). In addition, the expression level of PDGFR&#x3b2; was increased significantly at 7 and 14&#xa0;dpi compared with Pre and 3&#xa0;dpi (<italic>p</italic>&#x20;&#x3c; 0.001, <xref ref-type="fig" rid="F6">Figures 6A,D</xref>), consistent with immunofluorescence staining that PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes aggregated to the injury core (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). These preliminarily suggested that PDGFB rather than PDGFD may be involved in PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after&#x20;SCI.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>The expression of PDGFB is significantly increased after SCI or macrophages M2 polarization. <bold>(A)</bold> Western blot was used to detect the expression levels of PDGFB, PDGFD and PDGFR&#x3b2; before (Pre) and at 3, 7, and 14&#xa0;dpi in the injury core of mice (<italic>n</italic>&#x20;&#x3d; 5 per group). <bold>(B)</bold> Quantitative analysis of PDGFB in <bold>(A)</bold>. The blots were quantified as previously described. &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01, &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 (3 and 7&#xa0;dpi vs. pre); <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001, <sup>&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 (3 and 7&#xa0;dpi vs. 14&#xa0;dpi). <bold>(C)</bold> Quantitative analysis of PDGFD in <bold>(A)</bold>. &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001 (3, 7, and 14&#xa0;dpi vs. pre). <bold>(D)</bold> Quantitative analysis of PDGFR&#x3b2; in <bold>(A)</bold>. &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 (7, 14&#xa0;dpi vs. pre and 3&#xa0;dpi). <bold>(E)</bold> Western blot was used to detect the expression levels of PDGFB in M0, M1 or M2 macrophages (<italic>n</italic>&#x20;&#x3d; 5 per group). <bold>(F)</bold> Quantitative analysis of PDGFB in <bold>(E)</bold>, the blots were quantified as previously described, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 (M2 vs. M0), <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 (M2 vs. M1). <bold>(G)</bold> ELISA was used to detect the concentration of PDGFB in CM0, CM1 or CM2 (<italic>n</italic>&#x20;&#x3d; 5 per group), The results were expressed as mean&#x20;&#xb1; SD. &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 (CM2 vs. other groups).</p>
</caption>
<graphic xlink:href="fphar-12-670813-g006.tif"/>
</fig>
<p>Secondly, the expression level of PDGFB was detected after macrophage polarization <italic>in&#x20;vitro</italic>. The results of Western blot showed that the expression level of PDGFB in M2 macrophages was significantly higher than that in other groups (<italic>p</italic>&#x20;&#x3c; 0.01 and <italic>p</italic>&#x20;&#x3c; 0.001, respectively, <xref ref-type="fig" rid="F6">Figures 6E,F</xref>). Besides, the results of ELISA showed that the concentration of PDGFB in M2 macrophages culture medium was significantly higher than that in other groups (<italic>p</italic>&#x20;&#x3c; 0.01, <xref ref-type="fig" rid="F6">Figure&#x20;6G</xref>). These furtherly suggested that PDGFB may be involved in M2 macrophages promoting PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after&#x20;SCI.</p>
</sec>
<sec id="s3-7">
<title>M2 Macrophages Secrete PDGFB Acting on PDGFR&#x3b2; to Promote PDGFR&#x3b2;<sup>&#x2b;</sup> Pericytes Migration <italic>in Vitro</italic>
</title>
<p>To investigate the effect of M2 macrophages secretion of PDGFB on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration and its possible mechanism, SU16f (<xref ref-type="bibr" rid="B3">Andersen et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B15">Jiang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B5">Chatterjee et&#x20;al., 2019</xref>) was used to specifically inhibit PDGFR&#x3b2; and then the effect of exogenous PDGFB and M2 macrophages conditioned medium on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration were observed <italic>in&#x20;vitro</italic>. The scratch test showed that compared with Sham group, M2 conditioned medium and exogenous PDGFB significantly promoted the wound closure rate of pericytes (<italic>p</italic>&#x20;&#x3c; 0.0001) while the promotion effect was obviously eliminated by SU16f (<italic>p</italic>&#x20;&#x3c; 0.0001, <xref ref-type="fig" rid="F7">Figures 7A,C</xref>). Besides, transwell test also showed that after adding M2 conditioned medium or exogenous PDGFB, the number of pericytes passing through membrane increased significantly compared with other groups while the promotion effect was significantly eliminated by SU16f (<italic>p</italic>&#x20;&#x3c; 0.0001, <xref ref-type="fig" rid="F7">Figures 7B,D</xref>). These suggested that M2 macrophages promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration <italic>via</italic> PDGFB/PDGFR&#x3b2; pathway <italic>in&#x20;vitro.</italic>
</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>M2 macrophages secrete PDGFB acting on PDGFR&#x3b2; to promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration <italic>in&#x20;vitro</italic>. <bold>(A)</bold> Scratch test was used to detect the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after being treated with DMEM (Sham), conditioned medium of M2 macrophages (CM2), 10&#xa0;ng/ml recombinant mouse PDGFB protein (PDGFB), CM2 plus 10&#xa0;&#x3bc;m PDGFR&#x3b2; inhibitor (CM2&#x2b;SU16f) or PDGFB plus 10&#xa0;&#x3bc;M PDGFR&#x3b2; inhibitor (PDGFB&#x2b;SU16f) for 72&#xa0;h (<italic>n</italic>&#x20;&#x3d; 3 per group). <bold>(B)</bold> Transwell test was used to further detect the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after being treated in Sham, CM2, PDGFB, CM2 &#x2b; SU16f or PDGFB&#x2b;SU16f groups for 20&#xa0;h (<italic>n</italic>&#x20;&#x3d; 3 per group). <bold>(C)</bold> Quantitative analysis of the wound closure rate in <bold>(A)</bold>, the results were quantified as previously described, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001, &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 (groups vs. Sham), <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.0001 (groups vs. CM2 and PDGFB). <bold>(D)</bold> Quantitative analysis of the number of transmembrane cells in <bold>(B)</bold>, the results were quantified as previously described, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001 (CM2 and PDGFB vs. other groups). ND, not determined. Scale bars, 100&#xa0;&#x3bc;m. <bold>(E)</bold> Schematic representation. M2 macrophages could secrete PDGFB, acting on PDGFR&#x3b2; of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes, which promote the formation of fibrotic scar, corral macrophages and limit inflammation after SCI.</p>
</caption>
<graphic xlink:href="fphar-12-670813-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>At present, there is no effective treatment for SCI clinically, and investigating the pathological changes of SCI is expected to provide new ideas and therapeutic targets (<xref ref-type="bibr" rid="B22">Selvarajah et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B4">Bellver-Landete et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B19">Kobayakawa et&#x20;al., 2019</xref>). After SCI, oxidative stress caused by ischemia-reperfusion injury and inflammatory cytokines released by macrophages lead to the cascade of inflammatory responses (<xref ref-type="bibr" rid="B12">Hausmann, 2003</xref>; <xref ref-type="bibr" rid="B6">David and Kroner, 2011</xref>; <xref ref-type="bibr" rid="B21">Muradov et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B26">Tran et&#x20;al., 2018</xref>). Fibrotic scar surrounds macrophages to prevent inflammation from spreading while finally inhibits axonal regeneration (<xref ref-type="bibr" rid="B17">Klapka et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B7">Dias et&#x20;al., 2018</xref>). It has been reported that reducing of fibrotic scar formation could promote nerve regeneration and functional recovery (<xref ref-type="bibr" rid="B17">Klapka et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B7">Dias et&#x20;al., 2018</xref>). However, there are no specific drugs to eliminate fibrotic scar after SCI, and the mechanism of fibrotic scar formation is still unclear. Therefore, the study uncovering the mechanism of fibrotic scar formation after SCI is expected to provide new ideas and therapeutic targets.</p>
<p>Using genetic lineage tracing, <xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al. (2011)</xref> first identified a subset of pericytes as the source of the fibrotic scar after SCI in 2011, which was further confirmed by Jae K. Lee et&#x20;al. (<xref ref-type="bibr" rid="B24">Soderblom et&#x20;al., 2013</xref>). This subset of pericytes forming fibrotic scar express PDGFR&#x3b2; and CD13 as molecular markers while PDGFR&#x3b2; was expressed in all this subset of pericytes after SCI and can be used as a specific marker (<xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B24">Soderblom et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B7">Dias et&#x20;al., 2018</xref>). PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes are mainly distributed around large diameter vessels in the normal spinal cord. After SCI, PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes and macrophages gradually migrate and aggregate to the injury core (<xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B24">Soderblom et&#x20;al., 2013</xref>). Finally, PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes and extracellular matrix including Collagen, Fibronectin and Laminin surround the macrophages to form fibrotic scar, which prevents nerve regeneration (<xref ref-type="bibr" rid="B17">Klapka et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B11">G&#xf6;ritz et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B7">Dias et&#x20;al., 2018</xref>). The mechanism by which PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migrate and aggregate to the injury core is unclear. The spatiotemporal distribution of macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes is closely related after SCI, and the clearance of blood-derived macrophages resulted in the reduction of fibrotic scar in the injury core after SCI (<xref ref-type="bibr" rid="B29">Zhu et&#x20;al., 2015a</xref>). These suggest that macrophages may be involved in the migration and aggregation of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after SCI, which needs to be confirmed by further experiments. Mac2 has been shown to be a specific marker for blood-derived macrophages after SCI (<xref ref-type="bibr" rid="B28">Wang et&#x20;al., 2015</xref>). Therefore, we used anti-Mac2 antibody to specifically label macrophages rather than microglia and observed the spatiotemporal distribution of macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after SCI. The results showed that macrophages and PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes gradually migrated and aggregated to the injury core at 3&#x2013;7&#xa0;dpi while PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes surrounded macrophages and formed fibrotic scar at 14&#xa0;dpi, consistent with the conclusions of Jae K. Lee et&#x20;al. (<xref ref-type="bibr" rid="B29">Zhu et&#x20;al., 2015a</xref>). These further suggested that macrophages may be involved in the migration and aggregation of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after&#x20;SCI.</p>
<p>Macrophages play different roles due to M1 or M2 polarization in many diseases, which is important for oxidative stress, immune response and homeostasis repair (<xref ref-type="bibr" rid="B16">Kigerl et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B6">David and Kroner, 2011</xref>; <xref ref-type="bibr" rid="B14">Hu et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B28">Wang et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B27">Wang et&#x20;al., 2019</xref>). M1 macrophages are pro-inflammatory phenotypes with high expression of iNOS, CD16/32 and TNF-&#x3b1;, and have the functions of phagocytosis and clearance of pathogens. M2 macrophages are anti-inflammatory phenotypes, with high expression of CD206, Arg-1 and PDGF, and have the functions of growth stimulation, tissue repair and Collagen formation (<xref ref-type="bibr" rid="B16">Kigerl et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B6">David and Kroner, 2011</xref>). However, the effect and mechanism of macrophages polarization on the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to the injury core after SCI have not been reported. It has been reported that after SCI, most macrophages/microglial cells are M1 phenotype, with only a transient number showing M2 phenotype which occurs at 3&#x2013;7&#xa0;dpi (<xref ref-type="bibr" rid="B16">Kigerl et&#x20;al., 2009</xref>). Blood-derived macrophages can be distinguished from microglia based on the expression of Mac2, which provides a more accessible tool of studying macrophage polarization in addition to transgenic mice after SCI (<xref ref-type="bibr" rid="B28">Wang et&#x20;al., 2015</xref>). Therefore, in our study, Mac2<sup>&#x2b;</sup> iNOS<sup>&#x2b;</sup> and Mac2<sup>&#x2b;</sup> CD206<sup>&#x2b;</sup> were used to label M1 and M2 macrophages, respectively. Our results showed that at 3&#x2013;7&#xa0;dpi, PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes gradually migrated and aggregated to the injury core, while macrophages were mainly M2 phenotype at this time. At 14&#xa0;dpi, PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes had surrounded macrophages to form fibrotic scar, while macrophages were mainly M1 phenotype at this time. Our results on the polarization of macrophages after SCI are consistent with the study from <xref ref-type="bibr" rid="B16">Kigerl et&#x20;al. (2009)</xref>. These suggested that M2 macrophages may be involved in the migration and aggregation of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after&#x20;SCI.</p>
<p>To further investigate the effect and mechanism of M2 macrophages on PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after SCI, RAW 264.7&#xa0;cells and MBVP cells were used for <italic>in&#x20;vitro</italic> studies. The scratch test and transwell test showed that after adding M2 conditioned medium, the migration ability of PDGFR&#x3b2;<sup>&#x2b;</sup> pericyte was significantly enhanced. These suggested that M2 macrophages could promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration <italic>in&#x20;vitro</italic>, and this effect of promoting migration may be due to exocrine of certain cytokines by M2 macrophages.</p>
<p>PDGFR&#x3b2;, as a specific marker of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes, is a receptor subtype of the PDGF family (<xref ref-type="bibr" rid="B18">Klinkhammer et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B23">Sil et&#x20;al., 2018</xref>). It has been reported that only PDGFB and PDGFD can activate PDGFR&#x3b2; and play important roles in cell migration and differentiation (<xref ref-type="bibr" rid="B9">Evrova and Buschmann, 2017</xref>). Moreover, <xref ref-type="bibr" rid="B8">Dubrac et&#x20;al. (2018)</xref> showed that PDGFB can activate pericyte surface PDGFR&#x3b2; to regulate pericyte migration in the retinal tissue. However, the role of PDGFB/PDGFR&#x3b2; pathway in PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after SCI has not been reported. Our results showed that the expression of PDGFB increased significantly at 3&#xa0;dpi, reached its peak at 7&#xa0;dpi, while decreased significantly at 14&#xa0;dpi. The expression of PDGFD was significantly decreased at 3, 7, and 14&#xa0;dpi. These suggested that PDGFB may be involved in the migration of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes after SCI. Besides, the expression of PDGFB was significantly increased after M2 polarization of macrophages <italic>in&#x20;vitro</italic>, which led us to speculate that M2 macrophages may activate PDGFR&#x3b2; by secreting PDGFB, promoting PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after SCI. To test this hypothesis, we used SU16f to specifically block pericytes surface PDGFR&#x3b2; (<xref ref-type="bibr" rid="B3">Andersen et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B15">Jiang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B5">Chatterjee et&#x20;al., 2019</xref>) and observed the effect of M2 macrophage conditioned medium or exogenous PDGFB on PDGFR&#x3b2;<sup>&#x2b;</sup> pericyte migration <italic>in&#x20;vitro</italic>. The scratch test and transwell test showed that after adding M2 conditioned medium, PDGFR&#x3b2;<sup>&#x2b;</sup> pericyte migration ability was significantly enhanced, but this promotion effect could be blocked by SU16f. These suggested that M2 macrophages secrete PDGFB acting on PDGFR&#x3b2; to promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration after SCI (<xref ref-type="fig" rid="F7">Figure&#x20;7E</xref>).</p>
<p>Our study also showed that M2 macrophages could promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes secretion of extracellular matrix such as Laminin, but the molecular mechanism needs to be further studied. Although PDGFR&#x3b2; was expressed in all the subset of pericytes forming fibrotic scar after SCI, a small number of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes were distributed around large diameter vessels. Therefore, studies of SU16f as a PDGFR&#x3b2; specific inhibitor should be evaluated for its side effects on angiogenesis and vascular function. In addition, systematic <italic>in vivo</italic> experiments are needed to further confirm our conclusions.</p>
<p>In conclusion, the present study demonstrated that macrophages are closely related to the spatiotemporal distribution of PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes in the injury core at 3, 7, and 14&#xa0;dpi. Macrophages appear M2 polarization at 3 and 7&#xa0;dpi while M1 polarization at 14&#xa0;dpi. M2 macrophages can promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes migration <italic>via</italic> PDGFB/PDGFR&#x3b2; pathway, which can be blocked by a PDGFR&#x3b2; specific inhibitor SU16f. Besides, M2 macrophages can promote PDGFR&#x3b2;<sup>&#x2b;</sup> pericytes to secrete extracellular matrix. These suggested that PDGFB/PDGFR&#x3b2; pathway is a promising new target for the treatment of&#x20;SCI.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Animal Ethics Committee of Anhui Medical University.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>JJ, LC, and MZ contributed to the conception and design of the research. ZL and SY performed the experiments, interpreted the results of the experiments, and edited and revised the manuscript. FY and YL performed part of the experiments. DT and YL prepared the figures and analyzed the data. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This study was supported by Key Research and Development Projects of Anhui Province (Grant number 202004j07020042) and the National Natural Science Foundation of China (Grant number 81801220 and 81671204).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ack>
<p>Thanks for the experiment platform provided by the Scientific Research and Experiment Center of the Second Hospital of Anhui Medical University.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abramsson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kurup</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Busse</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lindblom</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schallmeiner</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development</article-title>. <source>Genes Dev.</source> <volume>21</volume> (<issue>3</issue>), <fpage>316</fpage>&#x2013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1101/gad.398207</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abramsson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lindblom</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Betsholtz</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>112</volume> (<issue>8</issue>), <fpage>1142</fpage>&#x2013;<lpage>1151</lpage>. <pub-id pub-id-type="doi">10.1172/jci1854910.1172/jci200318549</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Zaher</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Ditzel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Drews</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wruck</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Association between <italic>in vivo</italic> bone formation and <italic>ex vivo</italic> migratory capacity of human bone marrow stromal cells</article-title>. <source>Stem Cell Res. Ther.</source> <volume>6</volume>, <fpage>196</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-015-0188-9</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellver-Landete</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bretheau</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mailhot</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Valli&#xe8;res</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lessard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Janelle</surname>
<given-names>M.-E.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury</article-title>. <source>Nat. Commun.</source> <volume>10</volume> (<issue>1</issue>), <fpage>518</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-08446-0</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Berdnikov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Buchel</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Paracrine crosstalk between fibroblasts and ER&#x2b; breast cancer cells creates an il1&#x3b2;-enriched niche that promotes tumor growth</article-title>. <source>iScience</source> <volume>19</volume>, <fpage>388</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2019.07.034</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kroner</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Repertoire of microglial and macrophage responses after spinal cord injury</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>12</volume> (<issue>7</issue>), <fpage>388</fpage>&#x2013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3053</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Holl</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Werne Solnestam</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lundeberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Carl&#xe9;n</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Reducing pericyte-derived scarring promotes recovery after spinal cord injury</article-title>. <source>Cell</source> <volume>173</volume> (<issue>1</issue>), <fpage>153</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.004</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubrac</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>K&#xfc;nzel</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>K&#xfc;nzel</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chandran</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy</article-title>. <source>Nat. Commun.</source> <volume>9</volume> (<issue>1</issue>), <fpage>3463</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-05926-7</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evrova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Buschmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Buschmann</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> effects of PDGF-BB delivery strategies on tendon healing: a review</article-title>. <source>Eur. Cell Mater.</source> <volume>34</volume>, <fpage>15</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.22203/eCM.v034a02</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Phyllolobium chinense fisch flavonoids (PCFF) suppresses the M1 polarization of LPS-stimulated RAW264.7 macrophages by inhibiting NF-&#x3ba;B/iNOS signaling pathway</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>864</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00864</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf6;ritz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Tomilin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Barbacid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shupliakov</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fris&#xe9;n</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A pericyte origin of spinal cord scar tissue</article-title>. <source>Science</source> <volume>333</volume> (<issue>6039</issue>), <fpage>238</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1126/science.1203165</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausmann</surname>
<given-names>O. N.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Post-traumatic inflammation following spinal cord injury</article-title>. <source>Spinal Cord</source> <volume>41</volume> (<issue>7</issue>), <fpage>369</fpage>&#x2013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1038/sj.sc.3101483</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiroi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sakaeda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohmori</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Anti-inflammatory cytokine interleukin-4 inhibits inducible nitric oxide synthase gene expression in the mouse macrophage cell line RAW264.7 through the repression of octamer-dependent transcription</article-title>. <source>Mediators Inflamm.</source> <volume>2013</volume>, <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1155/2013/369693</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Leak</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suenaga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Microglial and macrophage polarization-new prospects for brain repair</article-title>. <source>Nat. Rev. Neurol.</source> <volume>11</volume> (<issue>1</issue>), <fpage>56</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.207</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Arpke</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Kyba</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A PPAR&#x3b3; transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>15926</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms15926</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kigerl</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Gensel</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Ankeny</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.&#x20;K.</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Popovich</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord</article-title>. <source>J.&#x20;Neurosci.</source> <volume>29</volume> (<issue>43</issue>), <fpage>13435</fpage>&#x2013;<lpage>13444</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3257-09.2009</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klapka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hermanns</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Straten</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Masanneck</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hamers</surname>
<given-names>F. P. T.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery</article-title>. <source>Eur. J.&#x20;Neurosci.</source> <volume>22</volume> (<issue>12</issue>), <fpage>3047</fpage>&#x2013;<lpage>3058</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04495.x</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klinkhammer</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Floege</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boor</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>PDGF in organ fibrosis</article-title>. <source>Mol. Aspects Med.</source> <volume>62</volume>, <fpage>44</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2017.11.008</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayakawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohkawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yoshizaki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tamaru</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kijima</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Macrophage centripetal migration drives spontaneous healing process after spinal cord injury</article-title>. <source>Sci. Adv.</source> <volume>5</volume> (<issue>5</issue>), <fpage>eaav5086</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.aav5086</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonough</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monterrubio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ariza</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Cerde&#xf1;o</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Calibrated forceps model of spinal cord compression injury</article-title>. <source>J.&#x20;Vis. Exp.</source> <volume>24</volume> (<issue>98</issue>), <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3791/52318</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muradov</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Ewan</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Hagg</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Dorsal column sensory axons degenerate due to impaired microvascular perfusion after spinal cord injury in rats</article-title>. <source>Exp. Neurol.</source> <volume>249</volume>, <fpage>59</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.08.009</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selvarajah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>E. B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Trends in traumatic spinal cord injury</article-title>. <source>JAMA</source> <volume>314</volume> (<issue>15</issue>), <fpage>1643</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.11194</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Periyasamy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thangaraj</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chivero</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Buch</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>PDGF/PDGFR axis in the neural systems</article-title>. <source>Mol. Aspects Med.</source> <volume>62</volume>, <fpage>63</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2018.01.006</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soderblom</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lyapichev</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury</article-title>. <source>J.&#x20;Neurosci.</source> <volume>33</volume> (<issue>34</issue>), <fpage>13882</fpage>&#x2013;<lpage>13887</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2524-13.2013</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stratman</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Schwindt</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Malotte</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>G. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization</article-title>. <source>Blood</source> <volume>116</volume> (<issue>22</issue>), <fpage>4720</fpage>&#x2013;<lpage>4730</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-05-286872</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tran</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Silver</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The biology of regeneration failure and success after spinal cord injury</article-title>. <source>Physiol. Rev.</source> <volume>98</volume> (<issue>2</issue>), <fpage>881</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00017.2017</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis</article-title>. <source>Nat. Commun.</source> <volume>10</volume> (<issue>1</issue>), <fpage>755</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-08680-6</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris</article-title>. <source>Glia</source> <volume>63</volume> (<issue>4</issue>), <fpage>635</fpage>&#x2013;<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22774</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Soderblom</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ashbaugh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bethea</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;K.</given-names>
</name>
</person-group> (<year>2015a</year>). <article-title>Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury</article-title>. <source>Neurobiol. Dis.</source> <volume>74</volume>, <fpage>114</fpage>&#x2013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.10.024</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Soderblom</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Trojanowsky</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.-H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;K.</given-names>
</name>
</person-group> (<year>2015b</year>). <article-title>Fibronectin matrix assembly after spinal cord injury</article-title>. <source>J.&#x20;Neurotrauma</source> <volume>32</volume> (<issue>15</issue>), <fpage>1158</fpage>&#x2013;<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2014.3703</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>